Skip to main content
NVDA-2.41%AAPL+3.21%GOOGL+0.58%MSFT-0.25%AMZN-0.28%TSM-1.35%SPCX+0.05%AVGO-0.64%META-1.57%TSLA-0.97%SKHY-4.36%MU-4.38%BRK-B-0.11%LLY0.00%JPM-0.50%WMT-0.08%AMD-2.96%V-0.18%XOM+0.61%ASMLa-1.66%JNJ-0.19%INTC-4.87%MA-0.57%0700.HK-1.94%1398.HK+0.79%ORCL-4.73%ABBV+1.14%BAC-0.31%CSCO-1.46%CVX-0.41%COST-0.24%KO+0.52%LRCX-4.97%CAT-1.49%AP2d-1.55%0005.HK-0.78%AMAT-2.59%UNH-0.91%HSBA.L-1.30%DELL-3.79%PG+0.27%MS-0.94%GE-0.66%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-1.70%0939.HK+1.66%GS-1.09%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.38%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.23%CADJPY-1.20%NZDCHF-1.06%USDZAR+1.05%USDNOK+0.90%USDSEK+0.88%EURZAR+0.86%AUDNZD+0.79%GBPZAR+0.78%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%EURSEK+0.69%AUDDKK-0.66%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.59%USDMXN+0.56%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.54%USDPLN+0.45%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.40%USDCHF+0.40%NOKJPY-0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%NZDMXN-0.17%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.08%EURCZK-0.07%PLNJPY+0.07%EURCNH-0.06%CHFSGD-0.05%AUDNOK+0.04%EURCAD-0.04%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%EURUSD-0.02%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.02%EURDKK0.00%XPTUSD-6.08%UKOIL+5.66%USOIL+5.54%XAGUSD-5.36%GAGUSD-5.36%HG1-4.86%XAUUSD-1.73%GAUUSD-1.73%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.51%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-3.01%SOLUSD-1.77%TRXUSDT+0.15%ZECUSDT-9.53%DOGEUSD-2.71%XMRUSDT+0.59%LINKUSD-1.57%XLMUSD-1.49%BCHUSDT-9.87%LTCUSD-1.60%UNIUSD-1.34%TONUSD+24.88%HBARUSDT-2.23%SUIUSD-4.46%TAOUSDT-5.65%AAVEUSD-2.40%DOTUSDT-2.01%ICPUSDT-1.12%ONDOUSDT-3.48%WLDUSDT-3.39%ATOMUSDT-3.41%ARBUSDT-0.56%JUPUSDT-3.82%INJUSDT-2.40%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.13%PYTHUSDT-1.52%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.77%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.76%IOTAUSDT-4.23%AXSUSDT-2.47%FARTCOINUSDT-3.11%EOSUSDT-2.91%DYDXUSDT-2.57%ORDIUSDT-0.84%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.41%AAPL+3.21%GOOGL+0.58%MSFT-0.25%AMZN-0.28%TSM-1.35%SPCX+0.05%AVGO-0.64%META-1.57%TSLA-0.97%SKHY-4.36%MU-4.38%BRK-B-0.11%LLY0.00%JPM-0.50%WMT-0.08%AMD-2.96%V-0.18%XOM+0.61%ASMLa-1.66%JNJ-0.19%INTC-4.87%MA-0.57%0700.HK-1.94%1398.HK+0.79%ORCL-4.73%ABBV+1.14%BAC-0.31%CSCO-1.46%CVX-0.41%COST-0.24%KO+0.52%LRCX-4.97%CAT-1.49%AP2d-1.55%0005.HK-0.78%AMAT-2.59%UNH-0.91%HSBA.L-1.30%DELL-3.79%PG+0.27%MS-0.94%GE-0.66%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-1.70%0939.HK+1.66%GS-1.09%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.38%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.23%CADJPY-1.20%NZDCHF-1.06%USDZAR+1.05%USDNOK+0.90%USDSEK+0.88%EURZAR+0.86%AUDNZD+0.79%GBPZAR+0.78%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%EURSEK+0.69%AUDDKK-0.66%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.59%USDMXN+0.56%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.54%USDPLN+0.45%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.40%USDCHF+0.40%NOKJPY-0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%NZDMXN-0.17%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.08%EURCZK-0.07%PLNJPY+0.07%EURCNH-0.06%CHFSGD-0.05%AUDNOK+0.04%EURCAD-0.04%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%EURUSD-0.02%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.02%EURDKK0.00%XPTUSD-6.08%UKOIL+5.66%USOIL+5.54%XAGUSD-5.36%GAGUSD-5.36%HG1-4.86%XAUUSD-1.73%GAUUSD-1.73%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.51%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-3.01%SOLUSD-1.77%TRXUSDT+0.15%ZECUSDT-9.53%DOGEUSD-2.71%XMRUSDT+0.59%LINKUSD-1.57%XLMUSD-1.49%BCHUSDT-9.87%LTCUSD-1.60%UNIUSD-1.34%TONUSD+24.88%HBARUSDT-2.23%SUIUSD-4.46%TAOUSDT-5.65%AAVEUSD-2.40%DOTUSDT-2.01%ICPUSDT-1.12%ONDOUSDT-3.48%WLDUSDT-3.39%ATOMUSDT-3.41%ARBUSDT-0.56%JUPUSDT-3.82%INJUSDT-2.40%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.13%PYTHUSDT-1.52%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.77%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.76%IOTAUSDT-4.23%AXSUSDT-2.47%FARTCOINUSDT-3.11%EOSUSDT-2.91%DYDXUSDT-2.57%ORDIUSDT-0.84%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
AP

Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ • Healthcare

$17.25
+$0.19 (+1.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$17.27
Previous Close$17.25
Day Range$17.08 - $17.36
Avg. Volume (3M)1.7M
Market Cap$5.4B
P/E Ratio34.5
52 Week Range
$9.49$19.26
Next EarningsIn 49 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$796.1M100%
Gross Profitminus cost of goods$334.5M42%
Operating Incomeminus R&D and overhead$145.9M18%
Net Incomeminus taxes and the rest$57.6M7%

In plain terms: out of every $100 in revenue, Amneal Pharmaceuticals, Inc. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$3.1B
Net Income (TTM)
$157.3M
EPS (TTM)
$0.5
ROA (TTM)
4.17%
Current Ratio
2.2
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+16.7%Q1 2026$0.21
+58.8%Q2 2026$0.27
+34.8%Q3 2026$0.3
Next

Oct 29

in 49 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) develops, makes, and sells generic and branded medicines in the healthcare sector, with additional distribution of medical supplies and related services. Across its pharmaceutical manufacturing and supply businesses, Amneal generated $3.0 billion of revenue in FY2025.

Name
Amneal Pharmaceuticals, Inc.
CEO
Chirag K. Patel
Website
www.amneal.com
Industry
Healthcare
Year Founded
2002
Employees
8,700

Today's Snapshot

AI-generated

AMRX is trading 2.1% lower at 16.88, in line with a weaker sector.

Trading Volume

Below 10d avg (1.6M)

543.3K

vs S&P 500 Today

Underperforming Market

-1.53%

Updated: September 10, 2026 at 19:05 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
AMRX shows a mixed short-term picture that leaves the technicals neutral. Momentum indicators are skewed toward weakness with a below‑50 RSI and a negative MACD, while ultra-oscillators register oversold readings that have triggered short-term buy signals; price sits below the 10–50 day averages but remains above the 100/200-day moving averages, indicating longer-term support. Trend strength is muted with ADX near the mid-teens and volatility is modest given an ATR around $0.53. Weak on‑balance volume and a VWAP slightly above the market add short-term pressure. Technical takeaway: Neutral — short-term weakness inside longer-term support.
All signals
  • EMA (5 indicators)$14.68 - $17.63
    Sell
  • RSI (14)39.76
    Neutral
  • Stochastic %K (14, 3, 3)8.86
    Buy
  • MACD Level (12, 26)-0.14
    Sell

Peers & Related Assets

LNTHLantheus Holdings, Inc.
$100.7+0.3%
MIRMMirum Pharmaceuticals, Inc.
$98.3-1.2%
INDVIndivior Pharmaceuticals Inc
$34.77+1.3%
NVSTEnvista Holdings Corp
$26.42-1.4%
DYNDyne Therapeutics, Inc.
$19.19-5.5%
SUPNSupernus Pharmaceuticals, Inc.
$42.07-0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.